SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000010
Filing Date
2018-03-13
Accepted
2018-03-13 09:07:59
Documents
3
Period of Report
2018-03-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ebio-form8xkvistapr.htm 8-K 30733
2 EXHIBIT 99.1 ebio-vistaenrollmentvfinal.htm EX-99.1 16761
3 elevenlogoa04.jpg GRAPHIC 8456
  Complete submission text file 0001485003-18-000010.txt   60283
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18685370
SIC: 2834 Pharmaceutical Preparations